Accendra Health INC/VA/ (ACH) intrinsic value & 10-year financials
Accendra Health INC/VA/ (ACH) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 13.1% a year to $2.8B, with an average return on invested capital of 2.5%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.23
- Market cap
- $18.1M
- Revenue (FY2025)
- $2.8B
- Revenue growth (10-yr CAGR)
- -13.1%
- ROIC (10-yr avg)
- 2.5%
- Free cash flow (FY2025)
- -$292.7M
ACH 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.8B | -$1.1B | -$14.31 | -$292.7M | 1.0% | 1.6% |
| FY2024 | $10.7B | -$362.7M | -$4.73 | -$49.4M | -1.9% | -8.5% |
| FY2023 | $10.3B | -$41.3M | -$0.54 | $549.8M | 1.0% | 2.7% |
| FY2022 | $10.0B | $22.4M | $0.29 | $166.9M | 1.4% | 5.5% |
| FY2021 | $9.8B | $221.6M | $2.94 | $83.2M | 3.8% | 17.1% |
| FY2020 | $8.5B | $29.9M | $0.47 | $288.8M | 2.4% | 6.7% |
| FY2019 | $9.2B | -$62.4M | -$1.03 | $123.7M | 0.8% | 3.4% |
| FY2018 | $9.8B | -$437.0M | — | $70.7M | -4.0% | -18.8% |
| FY2017 | $9.3B | $72.8M | — | $22.2M | 1.0% | 5.7% |
| FY2016 | $9.7B | $108.8M | $1.76 | $166.6M | 2.1% | 9.4% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
ACCENDRA HEALTH INC/VA/ is facing top-line stagnation, with revenue contracting over the decade.
ACCENDRA HEALTH INC/VA/ has historically struggled to out-earn its cost of capital, averaging just 2.5% ROIC.
Over the decade, ACCENDRA HEALTH INC/VA/ shows that the company has leveraged its balance sheet to sustain operations.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, ACCENDRA HEALTH INC/VA/ is modeled at -13.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-4.40 per share.